Increased levels of endothelial haemostatic markers in patients with coronary heart disease

被引:35
|
作者
Schumacher, A
Seljeflot, I
Sommervoll, L
Christensen, B
Otterstad, JE
Arnesen, H
机构
[1] Vestfold Cent Hosp, Dept Microbiol, N-3103 Tonsberg, Norway
[2] Vestfold Cent Hosp, Dept Med, N-3103 Tonsberg, Norway
[3] Ulleval Univ Hosp, Ctr Clin Res, Oslo, Norway
[4] Ulleval Univ Hosp, Dept Med Genet, Oslo, Norway
关键词
von Willebrand factor; thrombomodulin; tissue plasminogen activator; coronary heart disease;
D O I
10.1016/S0049-3848(01)00399-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand factor (vWF), thrombomodulin and tissue plasminogen activator antigen (tPAag) are regarded as markers of endothelial activation and/or damage. Elevated levels have been associated with atherosclerotic disease states. The aim of the present study was to compare the levels of vWF, thrombomodulin and tPAag in patients with coronary heart disease (CHD) and matched healthy individuals to see if they discriminated significantly between the study groups also after adjustment for established CHD risk factors. Patients (n = 193) in various stages of CHD and matched controls (n = 193) were included. To evaluate possible influence of acute phase reaction, reinvestigation was performed alter 6 months. We observed elevated levels of vWF (P<.001) and tPAag (P<.001) but not thrombomodulin (P=.082) in CHD patients when compared to controls, still statistically significant after 6 months and also after adjustment for established risk factors. Our results indicate that vWF and tPAag but not thrombomodulin in the present population are independent markers of atherosclerosis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [1] Increased levels of markers of vascular inflammation in patients with coronary heart disease
    Schumacher, A
    Seljeflot, I
    Sommervoll, L
    Christensen, B
    Otterstad, JE
    Arnesen, H
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2002, 62 (01): : 59 - 68
  • [2] BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS
    Romanova, Valentyna
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 115 - 116
  • [3] Incremental shuttle walking is associated with activation of haemostatic and haemorheologic markers in patients with coronary heart disease
    Lee, KW
    Ingram, J
    Jolly, K
    Lip, GYH
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 51 - 51
  • [4] Incremental shuttle walking is associated with activation of haemostatic and haemorheologic markers in patients with coronary heart disease
    Lee, KW
    Ingram, J
    Jolly, K
    Lip, GYH
    HEART, 2004, 90 : A53 - A53
  • [5] PROGNOSTIC SIGNIFICANCE OF MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE
    Romanova, V. O.
    Kuzminova, N. V.
    Marchak, T. V.
    Lozinsky, S. E.
    Knyazkova, I. I.
    Kulchytska, O. M.
    Shkarivsky, Yu. L.
    WORLD OF MEDICINE AND BIOLOGY, 2022, 81 (03): : 148 - 152
  • [6] Increased prevalence of haemostatic abnormalities and osteoarthritis in a young cohort of patients with coronary heart disease and mixed hyperlipidemia
    Cheras, PA
    Colquhoun, DM
    Neilsen, GVL
    Dubois, P
    Outerbridge, HK
    Battistutta, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S61 - S61
  • [7] Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease
    Miller, GJ
    Bauer, KA
    Barzegar, S
    Cooper, JA
    Rosenberg, RD
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (05) : 767 - 771
  • [8] MARKERS OF ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS DEPENDING ON ARTERIAL HYPERTENSION PRESENCE
    Romanova, Valentyna
    Kuzminova, Nataliia
    Romanova, Lidiia
    Ivankova, Anastasiia
    JOURNAL OF HYPERTENSION, 2023, 41 : E177 - E178
  • [9] Haemostatic factors and risk of coronary heart disease
    De Lorenzo, F
    Kadziola, Z
    Kakkar, VV
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (02) : 113 - 114
  • [10] Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease
    S. G. Wannamethee
    G. D. O. Lowe
    A. G. Shaper
    A. Rumley
    L. Lennon
    P. H. Whincup
    Diabetologia, 2004, 47 : 1557 - 1565